1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

  • March 2016
  • -
  • International Market Analysis Research and Consult
  • -
  • 44 pages

IMARC’s new report “Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japan diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Japan diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Japanese diabetes epidemiology and its dynamics:

Focus of the Analysis:

Historical, current and future prevalence of diabetes in Japan
Historical, current and future prevalence of type-1 and type-2 diabetes in Japan
Historical, current and future prevalence of diabetes in the urban and rural regions in Japan
Historical, current and future prevalence of diabetes among males and females in Japan
Historical, current and future prevalence of diabetes among various age groups in Japan
Historical, current and future diagnosis rates for diabetes in Japan
Historical, current and future drug treatment rates for diabetes in Japan
Comprehensive situation analysis of the Japanese Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

Performance of the Oral Antidiabetics market in Japan
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Japanese Insulin market and its dynamics:

Focus of the Analysis:

Performance of the Insulin market in Japan
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Japanese diabetes diagnostics market and its dynamics:

Focus of the Analysis:

Performance of the diabetes diagnostics market in Japan
Market Segmentation
Key players
Market outlook

Table Of Contents

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics
1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
3.2.1 Diagnosis
3.2.2 Treatment
3.3 Diabetes Complications
4 Key Factors Driving the Diabetes Market in Japan
5 Japan Diabetes Epidemiology
5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group
5.6 Diabetes Diagnosis and Drug Treatment Rates
6 Japan Diabetes Market
6.1 Historical Market Trends
6.2 Market Outlook
6.3 Market Breakup by Segment
6.4 Japan Oral Antidiabetics Market
6.4.1 Historical Market Trends
6.4.2 Market Breakup by Class
6.4.3 Market Shares of Key Players
6.4.4 Market Outlook
6.5 Japan Insulin Market
6.5.1 Historical Market Trends
6.5.2 Market Breakup by Class
6.5.3 Market Shares of Key Players
6.5.4 Market Outlook
7 Japan Diabetes Diagnostics Market
7.1 Historical Market Trends
7.2 Market Segmentation
7.3 Key Players

List of Figures

Figure 3 1: The impact of Diabetes in the Human Body
Figure 3 2: Diabetes Complications
Figure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 and 2035
Figure 4 2: Japan: Overweight and Obese Population* (in Million), 2010, 2015. 2020
Figure 4 3: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 4 4: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 and 65+), (in %),
Figure 4 5 : Japan: Diabetes Prevalence By Age Groups, (in %),
Figure 5 1: Japan: Total Number of Diabetes Patients* (in 000), 2008-2015
Figure 5 2: Japan: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020
Figure 5 3: Japan (Type1 and Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015
Figure 5 4: India (Type1 and Type2): Total Number of Diabetes Patients* (in 000),2016-2020
Figure 5 5: Japan (Urban and Rural): Total Number of Diabetes Patients* (in 000), 2008 - 2015
Figure 5 6: Japan (Urban and Rural): Total Number of Diabetes Patients* (in 000), 2016 - 2020
Figure 5 7: Japan (Male and Female): Total Number of Diabetes Patients* (in 000), 2008 - 2015
Figure 5 8: Japan (Male and Female): Total Number of Diabetes Patients* (in 000), 2016 - 2020
Figure 5 9: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (in 000), 2008 - 2015
Figure 5 10: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (in 000), 2016 - 2020
Figure 6 1: Japan: Diabetes Drugs Market (in Million US$), 2008-2015
Figure 6 2: Japan: Diabetes Drug Market Forecast (in Million US$), 2016-2020
Figure 6 3: Japan: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016-2020
Figure 6 4: Japan: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2008-2015
Figure 6 5: Japan: Oral Antidiabetics Market: (in Million US$), 2008-2015
Figure 6 6: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008and2015
Figure 6 7: India: Oral Anti-diabetics Market: Sales Share of Key Players (in %),
Figure 6 8: Japan: Oral Antidiabetics Market: (in Million US$), 2016-2020
Figure 6 9: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 and2020
Figure 6 10: Japan: Insulin Market, (in Million US$), 2008-2015
Figure 6 11: Japan: Breakup of Insulin Market by Class (in %)
Figure 6 12: Japan: Insulin Market: Sales Share of Key Players (in %)
Figure 6 13: Japan: Insulin Market Forecast (in Million US$), 2016-2020
Figure 7 1: Japan: Diabetes Diagnostics Market (in Million US$), 2008-2015
Figure 7 2: Japan: Diabetes Diagnostics Market: Sales by Segment (in %)
Figure 7 3: Japan: Diabetes Diagnostics Market Forecast (in Million US$), 2016-2020

List of Tables

Table 3 1: Diagnosis of Diabetes
Table 4 1: Global: Diabetes Population Breakup by Country (in 000's), 2015 and 2035
Table 4 2: Japan: Overweight andObesity Statistics, 2010, 2015 and 2020
Table 4 3: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 and 65+), (in Million),
Table 5 1: Japan: Total Prevalence andNumber of Diabetes Patients*, 2008, 2015 and 2020
Table 5 2: Japan (Type1 and Type2): Total Prevalence and Number of Diabetes Patients, 2008, 2015 and 2020
Table 5 3: Japan (Urban and Rural): Total Prevalence and Number of Diabetes Patients, 2008, 2015 and 2020
Table 5 4: Japan (Male and Female): Total Prevalence and Number of Diabetes Patients, 2008, 2015 and 2020
Table 5 5: Total Prevalence and Number of Diabetes Patients by Age Group (20-39), (40-59) and (60-79) (In Millions), 2008, 2015 and 2020

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

  • $ 4995
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence ...

Diabetic Gastroparesis  - Market Insights, Epidemiology and Market Forecast-2023

Diabetic Gastroparesis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Diabetic Gastroparesis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Diabetic Gastroparesis fo ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.